(2''S,3aR,6S,7aR)- 3''- acetyl- 3a,7a- dihydro- 2,2,2'- 2',- tetramethyl- 5'- (4- bromophenyl)- spiro(spiro(1,3- dioxolo(4,5- D)- pyrane- 6(7H),5'(4'H)- 1',3'- dioxolo)- 7(6H),2''(3''H)- (1,3,4)- oxadiazole)
has anti-tumor metastatic activity, which partly depends on its inhibition of tumor adhesion; structure in first source
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
- Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
- Azoles: 2138
- Oxazoles: 89
- Oxadiazoles: 146
- (2''S,3aR,6S,7aR)-3''-acetyl-3a,7a-dihydro-2,2,2'-2',-tetramethyl-5'-(4-bromophenyl)-spiro(spiro(1,3-dioxolo(4,5-D)-pyrane-6(7H),5'(4'H)-1',3'-dioxolo)-7(6H),2''(3''H)-(1,3,4)-oxadiazole)
- Pyrans: 130
- (2''S,3aR,6S,7aR)-3''-acetyl-3a,7a-dihydro-2,2,2'-2',-tetramethyl-5'-(4-bromophenyl)-spiro(spiro(1,3-dioxolo(4,5-D)-pyrane-6(7H),5'(4'H)-1',3'-dioxolo)-7(6H),2''(3''H)-(1,3,4)-oxadiazole)
- Organic Chemicals: 133
- Hydrocarbons: 1713
- Cyclic Hydrocarbons: 97
- Spiro Compounds: 2
- (2''S,3aR,6S,7aR)-3''-acetyl-3a,7a-dihydro-2,2,2'-2',-tetramethyl-5'-(4-bromophenyl)-spiro(spiro(1,3-dioxolo(4,5-D)-pyrane-6(7H),5'(4'H)-1',3'-dioxolo)-7(6H),2''(3''H)-(1,3,4)-oxadiazole)
- Polycyclic Compounds: 6
- Spiro Compounds: 2
- (2''S,3aR,6S,7aR)-3''-acetyl-3a,7a-dihydro-2,2,2'-2',-tetramethyl-5'-(4-bromophenyl)-spiro(spiro(1,3-dioxolo(4,5-D)-pyrane-6(7H),5'(4'H)-1',3'-dioxolo)-7(6H),2''(3''H)-(1,3,4)-oxadiazole)